Tag
Novartis India Limited
5 articles
Novartis India Limited is undergoing a significant ownership transition, with Novartis AG having fully divested its 70.68% stake to a consortium of WaveRise and ChrysCapital, effectively reclassifying itself as a public shareholder. This change triggered a mandatory open offer to public shareholders, which received a minimal response, with virtually no shares tendered. While the company reported a slight year-over-year decrease in FY26 revenue and profit, it is pursuing brand consolidation and geographic expansion, alongside an Employee Stock Option Scheme. Investors should monitor the new ownership's strategic direction and the ongoing audit matters related to revenue recognition and tax disputes.
Novartis India Intimates Investor Conference Participation
Novartis India discloses official participation in Nuvama's Emerging India CEO Forum investor conference in Mumbai on September 28, 2026.
The company confirms meetings will include both one-on-one and
Novartis AG Sells Entire 70.68% Stake
Novartis AG sold its entire 70.68% holding (1.74 crore shares) in Novartis India Limited on July 29, 2026.
The sale was executed off-market pursuant to a purchase agreement dated February 19, 2026.
No
Novartis AG Sells Entire 70.68% Stake in Novartis India
Novartis AG sold its entire 70.68% stake, comprising 1.74 crore equity shares, in Novartis India Limited.
The off-market transaction was valued at approximately ₹1,376.89 crore and executed on July 29
Novartis AG Reclassified to Public Shareholder
Novartis AG completes sale of 70.68% stake in Novartis India to ChrysCapital entities, ceasing to be promoter.
ChrysCapital's WaveRise and Fund X acquire control, triggering a mandatory 26% open offer
WaveRise ChrysCapital Novartis India Open Offer Completion
Axis Capital submits post-offer ad for completed open offer by WaveRise Investments and ChrysCapital for 26% stake in Novartis India.
Open offer acquired 64.19 lakh shares at ₹5,524.97 crore total val